Literature DB >> 26487043

Cochrane in CORR1: Steroids for Acute Spinal Cord Injury (Review).

Nathan Evaniew, Marcel Dvorak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26487043      PMCID： PMC4686530          DOI： 10.1007/s11999-015-4601-6

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  17 in total

1.  The economic burden of traumatic spinal cord injury in Canada.

Authors:  H Krueger; V K Noonan; L M Trenaman; P Joshi; C S Rivers
Journal:  Chronic Dis Inj Can       Date:  2013-06

2.  Why we can't trust clinical guidelines.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2013-06-14

3.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; W F Collins; T R Holford; D S Baskin; H M Eisenberg; E Flamm; L Leo-Summers; J C Maroon; L F Marshall
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

Review 4.  Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review.

Authors:  Elie A Akl; Matthias Briel; John J You; Xin Sun; Bradley C Johnston; Jason W Busse; Sohail Mulla; Francois Lamontagne; Dirk Bassler; Claudio Vera; Mohamad Alshurafa; Christina M Katsios; Qi Zhou; Tali Cukierman-Yaffe; Azim Gangji; Edward J Mills; Stephen D Walter; Deborah J Cook; Holger J Schünemann; Douglas G Altman; Gordon H Guyatt
Journal:  BMJ       Date:  2012-05-18

5.  A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.

Authors:  M B Bracken; M J Shepard; W F Collins; T R Holford; W Young; D S Baskin; H M Eisenberg; E Flamm; L Leo-Summers; J Maroon
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

6.  Causes and costs of spinal cord injury in the United States.

Authors:  M J DeVivo
Journal:  Spinal Cord       Date:  1997-12       Impact factor: 2.772

7.  Methylprednisolone for acute spinal cord injury: 5-year practice reversal.

Authors:  R John Hurlbert; Mark G Hamilton
Journal:  Can J Neurol Sci       Date:  2008-03       Impact factor: 2.104

8.  Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.

Authors:  Mark C Simmonds; Jennifer V E Brown; Morag K Heirs; Julian P T Higgins; Richard J Mannion; Mark A Rodgers; Lesley A Stewart
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

9.  [Medical treatment of spinal cord injury in the acute stage].

Authors:  M E Petitjean; V Pointillart; F Dixmerias; L Wiart; F Sztark; P Lassié; M Thicoïpé; P Dabadie
Journal:  Ann Fr Anesth Reanim       Date:  1998

10.  Why do you prescribe methylprednisolone for acute spinal cord injury? A Canadian perspective and a position statement.

Authors:  R J Hurlbert; R Moulton
Journal:  Can J Neurol Sci       Date:  2002-08       Impact factor: 2.104
View more
  1 in total

1.  Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury.

Authors:  Min-Jae Jo; Hemant Kumar; Hari P Joshi; Hyemin Choi; Wan-Kyu Ko; J M Kim; Sean S S Hwang; Song Y Park; Seil Sohn; Alvin B Bello; Kyoung-Tae Kim; Soo-Hong Lee; Xiang Zeng; Inbo Han
Journal:  Front Pharmacol       Date:  2018-05-07       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.